NEWS・COLUMN

We send the latest information from SMC Laboratories.

2022.07.13

SMC attend BIO One-on-One Partnering™ in Bio Asia Taiwan!

We are pleased to announce that SMC Laboratories will be virtually attending the BIO One-on-One PartneringTM i…

READ MORE

2022.07.06

SMC announces Presentation of New Data at the 29th conference of The Japanese Society for the Research of Hepatic Cells.

Today, we are pleased to announce the acceptance of our abstract on our NASH-hepatocellular carcinoma (HCC) mo…

READ MORE

2022.06.30

PUBLICATION

GN Corporation publication in Journal of Clinical and Experimental Hepatology

SMC announces that GN Corporation Clinical and Experimental Hepatology (Japan) has published the results of a …

READ MORE

2022.06.21

PUBLICATION

Esperion Therapeutics's publication in Cell Metabolism

SMC announces that Esperion Therapeutics (MI, USA) has published the results of a study using STAM™&nbsp…

READ MORE

2022.06.10

PRODUCTS AND SERVICE

Potential NASH biomarker in NASH-HCC model

We would like to introduce the data for a serological marker from our NASH model (STAM™ model). Hepatoce…

READ MORE

2022.05.23

PUBLICATION

Drug efficacy studies in NASH mouse model

We would like to introduce a study published by our client using our proprietary non-alcoholic steatohepatitis…

READ MORE

2022.05.10

PRODUCTS AND SERVICE

Introducing our new model: DDC-induced liver injury model

We introduce the 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-induced liver injury model*, a well-known mod…

READ MORE

2022.04.29

Reserve a non-clinical pharmacology consultation with us at BIO KOREA 2022!

We will join BIO KOREA 2022 International Convention, one of the biggest bio-health conventions in Asia. BIO K…

READ MORE

2022.04.26

NEWS RELEASE

kk

We would like to introduce a study published by our client using our proprietary non-alcoholic steatohepatitis…

READ MORE

2022.04.16

NEWS RELEASE

Introduction of the paper using our UUO model

We would like to introduce a paper published by our client using Chronic kidney disease model.     &…

READ MORE

2022.04.01

NEWS RELEASE

Change in concept from non-alcoholic fatty liver disease to metabolic disorder related fatty liver disease

You may be aware of NAFLD (non-alcoholic fatty liver disease), but have you heard of MAFLD? Metabolic dysfunct…

READ MORE

2022.03.16

NEWS RELEASE

Drug efficacy studies using multiple mouse models to replicate human disease.

To date, numerous clinical trials have been conducted using existing and newly developed drugs in the field of…

READ MORE

Page 12 of 19First1011121314Last